(Q77965487)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395092%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395092%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

Moser PC

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395092%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Sanger DJ

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395092%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395092%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

9 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395092%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

372

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395092%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

127-134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395092%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395092%20AND%20SRC:MED&resulttype=core&format=json

5-HT1A receptor antagonists increase the activity of serotonergic cells in the dorsal raphe nucleus in rats treated acutely or chronically with citalopram

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Role of the serotonergic system in the forced swimming test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Inhibition of 8-OH-DPAT-induced elevation of plasma corticotrophin by the 5-HT1A receptor antagonist WAY100635

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Neither the 5-HT1A- nor the 5-HT2-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on forced-swimming-induced immobility in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Effects of MDL 73005EF on central pre- and postsynaptic 5-HT1A receptor function in the rat in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

(-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Pindolol augmentation of antidepressant therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Serotonergic function during lithium augmentation of refractory depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Effect of pindolol on hormone secretion and body temperature: partial agonist effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Augmentation strategies in patients with refractory depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

GR 127935 blocks the locomotor and antidepressant-like effects of RU 24969 and the action of antidepressants in the mouse tail suspension test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

On brightening up: triggers and trajectories to recovery from depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Behavioural despair in rats: A new model sensitive to antidepressant treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

The role of hippocampal 5-hydroxytryptamine 1A (5-HT1A) receptors in the anticonflict activity of beta-adrenoceptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Somatodendritic 5-HT1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

A review of the use of augmentation therapy for the treatment of resistant depression: implications for the clinician

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2

Synergistic neurochemical and behavioral effects of fluoxetine and 5-HT1A receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900202-2